Nabriva Therapeutics(NBRV)

【仑胜医药】新型抗生素中国III期桥接试验成功！Nabriva股价大涨40%

医药魔方2021-05-27 10:20

5月25日，仑胜医药和Nabriva公司宣布，在中国开展的lefamulin（醋酸截短侧耳素）用于治疗成人社区获得性细菌性肺炎（CABP）的III期桥接试验取得积极结果。受此消息影响Nabriva股价大涨40%。
Lefamulin最初由Nabriva开发，2018年3月仑胜医药获得在大中华区，包括中国大陆、香港、澳门、台湾开...查看全文

fffffffooooo2021-05-27 03:26

$Nabriva Therapeutics(NBRV)$今天做空可以，跌一晚上查看全文

清風竹影2021-05-26 23:51

$Nabriva Therapeutics(NBRV)$ 是时候该拉了……查看全文

鲜克有终72021-02-11 03:44

$Nabriva Therapeutics(NBRV)$ [跪了]12➕查看全文

有为的股价小宝石2020-12-26 02:38

$Nabriva Therapeutics(NBRV)$ @小秘书 这个合股了麻烦改一下查看全文

conkers2020-07-30 12:43

$Nabriva Therapeutics(NBRV)$ 这家伙现在都这价格了查看全文

是毛哥没错2020-07-17 22:30

$Nabriva Therapeutics(NBRV)$ 看分析马上要飞了查看全文

kev88872020-07-17 21:56

$Nabriva Therapeutics(NBRV)$$纳斯达克综合指数(.IXIC)$
劲揪 ✅✅✅查看全文

kev88872020-07-17 01:30

$Nabriva Therapeutics(NBRV)$$纳斯达克综合指数(.IXIC)$
Ⅴ时段查看全文

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-07-25 AccNo: 0001104659-18-046992 Size: 1 MB 网页链接

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-07-25 AccNo: 0001104659-18-046879 Size: 292 KB 网页链接

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-07-25 AccNo: 0001104659-18-046840 Size: 69 KB 网页链接

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 8-K - Current report Filed: 2018-07-25 AccNo: 0001104659-18-046811 Size: 2 MBItem 1.01: Entry into a Material Definitive AgreementItem 2.01: Completion of Acquisition or Disposition of AssetsItem 2.03: Creation of a Direct Fi...

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 内部交易: 2018-06-23,Chief Scientific Officer,Gelone Steven P. ,买入,10000普通股, $3.82

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 内部交易: 2018-06-22,CEO & Director,Broom Colin MD ,买入,5000普通股, $3.72

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 内部交易: 2018-06-22,Chief Medical Officer,Schranz Jennifer ,买入,5500普通股, $3.73

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 8-K - Current report Filed: 2018-06-19 AccNo: 0001104659-18-041049 Size: 20 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain...

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ DEF 14A - Other definitive proxy statements Filed: 2018-06-19 AccNo: 0001047469-18-004571 Size: 1 MB 网页链接

$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 内部交易: 2018-05-23,Chief Commercial Officer,Lavino Francesco Maria ,买入,2160普通股, $4.60